Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon to Identify Multiple Sclerosis Biomarkers for CDC

NEW YORK, Oct. 27 (GenomeWeb News) - Metabolon will identify disease biomarkers for multiple sclerosis for the US Centers for Disease Control and Prevention, the company said yesterday.


MS is an autoimmune disease that affects the central nervous system by destroying myelin, the protective fatty tissue covering nerve fibers.  Without myelin, nerves are unable to transmit signals to and from the brain.  It is estimated that more than 2.5 million people worldwide are affected by MS, with more than 400,000 diagnosed in the United Stateseach year.


John Ryals, president and CEO of Metabolon, said the company hopes to use metabolomics to find biomarkers that will determine a cause for the disease and that can be used to create a definitive diagnostic tool for it.


Financial terms of the research were not disclosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.